4//SEC Filing
DAVIE JOSEPH MD PHD 4
Accession 0001181431-09-018960
CIK 0000921506other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 2:19 PM ET
Size
18.1 KB
Accession
0001181431-09-018960
Insider Transaction Report
Form 4
DAVIE JOSEPH MD PHD
Director
Transactions
- Exercise/Conversion
Common Stock
2009-04-02$10.45/sh+7,500$78,375→ 8,392 total - Tax Payment
Common Stock
2009-04-02$19.92/sh−6,608$131,631→ 892 total - Tax Payment
Common Stock
2009-04-02$19.92/sh−5,430$108,166→ 2,962 total - Exercise/Conversion
Nonqualified Stock Option (right to buy)
2009-04-02−12,500→ 2,500 totalExercise: $8.74From: 2008-06-20Exp: 2018-05-20→ Common Stock (12,500 underlying) - Exercise/Conversion
Common Stock
2009-04-02$15.60/sh+7,500$117,000→ 7,500 total - Exercise/Conversion
Nonqualified Stock Option (right to buy)
2009-04-02−7,500→ 0 totalExercise: $10.45From: 2007-06-30Exp: 2017-05-31→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2009-04-02$8.74/sh+12,500$109,250→ 15,462 total - Tax Payment
Common Stock
2009-04-02$19.92/sh−8,397$167,268→ 7,065 total - Exercise/Conversion
Nonqualified Stock Option (right to buy)
2009-04-02−7,500→ 0 totalExercise: $15.60From: 2006-07-06Exp: 2016-06-06→ Common Stock (7,500 underlying)
Footnotes (3)
- [F1]All shares subject to the option grant were fully vested.
- [F2]All shares subject to the option grant were fully vested.
- [F3]The shares subject to the option grant vest as to 8.33% of the shares subject to the option grant per month over the twelve (12) month period following the date of grant.
Issuer
CV THERAPEUTICS INC
CIK 0000921506
Entity typeother
Related Parties
1- filerCIK 0001216660
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 2:19 PM ET
- Size
- 18.1 KB